About Noul
Noul is a company founded in 2015.. The company has 151 employees as of December 31, 2024. Noul operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Definiens and Pictor Labs, among others.
- Employees 151 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Noul Co Ltd.
-
Annual Revenue
$1.08 M (USD)-41.42as on Dec 31, 2024
-
Net Profit
$-15.24 M (USD)-37.67as on Dec 31, 2024
-
EBITDA
$-14.11 M (USD)-45.69as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
151
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Noul
Noul is a publicly listed company on the KRX with ticker symbol 376930 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Noul
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Noul
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Noul
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Noul Comparisons
Competitors of Noul
Noul operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Definiens and Pictor Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
|
| domain | founded_year | HQ Location |
Platform offering solutions for preventive health scans
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Noul
Frequently Asked Questions about Noul
When was Noul founded?
Noul was founded in 2015.
Who is the current CEO of Noul?
David Lim is the current CEO of Noul.
How many employees does Noul have?
As of Dec 31, 2024, the latest employee count at Noul is 151.
What is the annual revenue of Noul?
Annual revenue of Noul is $1.08M as on Dec 31, 2024.
What does Noul do?
Noul was founded in 2015 as a provider of AI-based digital microscope platforms focused on blood analysis within the healthcare sector. A decentralized diagnostic platform, miLab, is offered to support resource-limited medical facilities, clinics, and local hospitals. The full diagnostic workflow is digitized and automated, covering sample preparation through to analysis, with operations centered on improving efficiency in diagnostic processes.
Who are the top competitors of Noul?
Noul's top competitors include Aignostics, Pictor Labs and PathAI.
Is Noul publicly traded?
Yes, Noul is publicly traded on KRX under the ticker symbol 376930.
What is Noul's ticker symbol?
The ticker symbol of Noul is 376930 on KRX.